GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,514,000 | +1903.3% | 125,029 | +1522.7% | 0.31% | +1357.1% |
| Q3 2020 | $425,000 | +15.2% | 7,705 | +31.7% | 0.02% | +5.0% |
| Q2 2020 | $369,000 | +3254.5% | 5,850 | +4139.1% | 0.02% | – |
| Q4 2019 | $11,000 | 0.0% | 138 | -38.1% | 0.00% | – |
| Q3 2019 | $11,000 | -98.8% | 223 | -98.8% | 0.00% | -100.0% |
| Q2 2019 | $955,000 | +72.7% | 18,156 | +73.8% | 0.05% | +51.6% |
| Q1 2019 | $553,000 | -77.1% | 10,448 | -83.5% | 0.03% | -77.9% |
| Q3 2018 | $2,411,000 | -7.5% | 63,446 | +10.0% | 0.14% | -15.2% |
| Q2 2018 | $2,607,000 | +44.4% | 57,663 | +54.3% | 0.16% | +25.0% |
| Q1 2018 | $1,806,000 | +881.5% | 37,379 | +696.0% | 0.13% | +780.0% |
| Q4 2017 | $184,000 | -38.3% | 4,696 | -51.0% | 0.02% | -44.4% |
| Q3 2017 | $298,000 | +51.3% | 9,593 | +33.2% | 0.03% | +42.1% |
| Q2 2017 | $197,000 | -27.8% | 7,200 | -2.7% | 0.02% | -29.6% |
| Q1 2017 | $273,000 | +320.0% | 7,400 | +64.4% | 0.03% | +237.5% |
| Q4 2016 | $65,000 | -66.1% | 4,500 | -45.8% | 0.01% | -60.0% |
| Q3 2016 | $192,000 | – | 8,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |